154 related articles for article (PubMed ID: 22036986)
21. In silico drug discovery: tools for bridging the NCE gap.
Larvol BL; Wilkerson LJ
Nat Biotechnol; 1998 May; 16 Suppl():33-4. PubMed ID: 9591262
[No Abstract] [Full Text] [Related]
22. Advances in technology and business potential of new drug delivery systems.
Momin M; Disouza J; Patravale V
Drug Deliv Transl Res; 2016 Aug; 6(4):341. PubMed ID: 27365167
[No Abstract] [Full Text] [Related]
23. The power of genomics to transform the biotechnology industry.
Haseltine WA
Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259
[No Abstract] [Full Text] [Related]
24. Prescription for an ailing pharmaceutical industry.
Demain AL
Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826
[No Abstract] [Full Text] [Related]
25. Pfizer-Pharmacia: the smart fit for the future.
Wiggins WP
Expert Opin Investig Drugs; 2003 Jan; 12(1):1-3. PubMed ID: 12517249
[No Abstract] [Full Text] [Related]
26. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
Razvi ES
IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
[No Abstract] [Full Text] [Related]
27. The pharmaceutical industry--prices and progress.
Scherer FM
N Engl J Med; 2004 Aug; 351(9):927-32. PubMed ID: 15329432
[No Abstract] [Full Text] [Related]
28. Bigger companies for better drugs?
Lancet; 1995 Sep; 346(8975):585. PubMed ID: 7650996
[No Abstract] [Full Text] [Related]
29. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
[TBL] [Abstract][Full Text] [Related]
30. Carlo Incerti.
Incerti C
Nat Rev Drug Discov; 2008 Aug; 7(8):638. PubMed ID: 18670428
[No Abstract] [Full Text] [Related]
31. Psoriasis: TNF-alpha inhibitors and beyond.
Kincaid L
Drug Discov Today; 2005 Jul; 10(13):884-6. PubMed ID: 15993806
[No Abstract] [Full Text] [Related]
32. Preface of EuPAT 7 Special Issue - Inventing Tomorrow's Development and Manufacturing.
Rantanen J; Khinast J
Eur J Pharm Sci; 2016 Jul; 90():1. PubMed ID: 27324754
[No Abstract] [Full Text] [Related]
33. Open access chemical and clinical probes to support drug discovery.
Edwards AM; Bountra C; Kerr DJ; Willson TM
Nat Chem Biol; 2009 Jul; 5(7):436-40. PubMed ID: 19536100
[TBL] [Abstract][Full Text] [Related]
34. Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeutics.
Fitzgerald GA
Nat Rev Drug Discov; 2005 Oct; 4(10):815-8. PubMed ID: 16224453
[TBL] [Abstract][Full Text] [Related]
35. Achieving continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Badman C; Trout BL
J Pharm Sci; 2015 Mar; 104(3):779-80. PubMed ID: 25501284
[No Abstract] [Full Text] [Related]
36. Vaccine manufacturing: challenges and solutions.
Ulmer JB; Valley U; Rappuoli R
Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
[TBL] [Abstract][Full Text] [Related]
37. Drug Delivery 2007--New technologies, partnering and strategies for the future.
Stevenson L
IDrugs; 2007 Jun; 10(6):388-90. PubMed ID: 17642001
[No Abstract] [Full Text] [Related]
38. [Current challenges for the pharmaceutical research industry].
Chalchat B
Ann Pharm Fr; 1993; 51(1):16-25. PubMed ID: 8215118
[TBL] [Abstract][Full Text] [Related]
39. What's fueling the biotech engine?
Aggarwal S
Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
[No Abstract] [Full Text] [Related]
40. An interview with Steven M. Watkins, Ph.D., president and chief scientific officer, Lipomics Technologies, Inc. Interview by Vicki Glaser.
Watkins SM
Assay Drug Dev Technol; 2004 Aug; 2(4):339-43. PubMed ID: 15357914
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
